ReShape Lifesciences Inc expected to post a loss of 16 cents a share - Earnings Preview

Vyome Holdings

10/05/2024 12:39

* ReShape Lifesciences Inc  RSLS.OQ   RSLS.O  is expected
to show
a fall in quarterly revenue when it reports  results on May 13
(estimated) for the period ending March 31 2024
    * The San Clemente California-based  company is expected to
report
a 8.0% decrease in revenue to $2.104 million from $2.29 million
a year ago, according to the estimate from one analyst, based on
LSEG data.
    * ​LSEG's mean analyst estimate for ReShape Lifesciences Inc
is
for a loss of 16 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for ReShape
Lifesciences Inc is $1.00​, above​ its last closing price
of $0.17. ​​​

This summary was machine generated May 10 at 11:38 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)